Ten years of HPV vaccination in the Netherlands: current evidence and future challenges in HPV-related disease prevention

Ten years of HPV vaccination in the Netherlands: current evidence and future challenges in HPV-related disease prevention

Introduction: Girls-only vaccination against human papillomavirus (HPV) type 16 and 18 was implemented in the Netherlands in 2009. Despite the evidence of the efficacy against precancerous lesions, cross-protection induced by the vaccine and a greater potential for cancer prevention than cervical ca...

Full description

Bibliographic Details
Main Authors: V. Qendri, T. M. Schurink-Van ’t Klooster, J. A. Bogaards, J. Berkhof
Format: Article
Language:English
Published: Taylor & Francis Group 2018-12-01
Series:Expert Review of Vaccines
Subjects:
human papillomavirus
hpv vaccines
netherlands
effectiveness
cost-effectiveness
coverage
safety
surveillance
national immunization program
Online Access:http://dx.doi.org/10.1080/14760584.2018.1547196

Internet

http://dx.doi.org/10.1080/14760584.2018.1547196

Similar Items